Given that tyrosine hydroxylase, an enzyme responsible for dopamine synthesis, is iron-dependent [24] and iron deficiency impairs dopamine reuptake in a mouse model [25], iron deficiency is a side effect of long-term PPI treatment that is possibly associated with PD development. The gene discussed is TH; the disease is Iron deficiency anemia.